Trial intelligence / Profile preview

Nevirapine, FTC, and Tenofovir in HIV

NCT00344461Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
Mar 2004
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nevirapine, emtricitabine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by University of Maryland, Baltimore. Started Mar 2004; status: completed.

02

Drugs

nevirapineemtricitabinetenofovir disoproxil fumarate
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00344461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00344461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call